Trial Profile
An Opened, Non-controlled, Multi-center Study of M118102 in Subjects with Asteatosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Heparinoid (Primary)
- Indications Sebaceous gland disorders
- Focus Registrational; Therapeutic Use
- Sponsors Maruho
- 06 Jul 2017 New trial record